Research Article
lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma
Table 1
Baseline characteristics of MM patients.
| | NDMM (/) | Relative expression of lncRNA MSTRG.29039.1 | value |
| | 37 | | | | Gender | | | | | Male | 22 (59.45) | | 0.8649 | | Female | 15 (40.55) | | | Age | | | | | <65 | 22 (59.45) | | 0.2859 | | ≥65 | 15 (40.55) | | | Median | 63 | | | | ISS stage | | | | | I | 9 (24.32) | | 0.0417 | | II | 8 (21.62) | | | III | 20 (54.06) | 4 | | R-ISS stage | | | | | I | 9 (24.32) | | 0.2056 | | II | 20 (54.06) | | | III | 8 (21.62) | | | M protein type | | | | | IgG type | 18 (48.66) | | | | IgA type | 6 (16.21) | | | | IgM type | 0 | | | | Light chain type | 7 (18.92) | | | | Nonsecretary type | 6 (16.21) | | |
|
|